Search

everythinglearnresearchcommunity

for

Search:↓

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Switching immunosuppressants can improve hair regrowth and well-being in transplant patients experiencing hair loss.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

A new mouse model for vitiligo helps study immune responses and potential treatments.

JAK inhibitors show promise for treating alopecia areata, but more research is needed.

Stromal cells in melanoma promote tumor growth and spread.

A group has developed therapies that show promise for treating cancer and various other conditions.

Systemic corticosteroids help manage vitiligo by slowing progression and aiding repigmentation.

JAK inhibitors effectively treat severe atopic dermatitis and alopecia areata.

Belatacept may be a promising treatment for alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

TLR3 signaling enhances the immunosuppressive properties of human periodontal ligament stem cells.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Blocking Oncostatin M's role in the JAK-STAT pathway can stimulate hair growth in mice.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Non-myeloablative stem cell transplants are a promising, less toxic option for older or weaker patients, with fewer side effects and good outcomes.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

Sintilimab treatment caused hair loss but led to complete tumor remission.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

IL-23 inhibitors may help treat other skin conditions, but more research is needed.

Allergies, especially dust mite allergy, may worsen alopecia areata, and desensitization could help reduce its severity.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

HDAC inhibitors, like Vorinostat and Entinostat, can help regrow hair in alopecia areata.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.